Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain
Katarzyna Pawlik, Anna Piotrowska, Klaudia Kwiatkowski, et al.
Immunology (2020) Vol. 159, Iss. 4, pp. 413-428
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Neuropathic pain; what we know and what we should do about it
Peter A. Smith
Frontiers in Pain Research (2023) Vol. 4
Open Access | Times Cited: 24
CC Chemokine Family Members’ Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury—A Review of Clinical and Experimental Findings
A Ciechanowska, Joanna Mika
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3788-3788
Open Access | Times Cited: 10
Bidirectional two-sample Mendelian randomization analysis reveals a causal effect of interleukin-18 levels on postherpetic neuralgia risk
Liang Xiao, Yuchao Fan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery
Haneen A. Al‐Mazroua, Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.
Molecular Immunology (2022) Vol. 144, pp. 127-137
Closed Access | Times Cited: 26
CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
Joanna Bogacka, Katarzyna Pawlik, Katarzyna Ciapała, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15638-15638
Open Access | Times Cited: 25
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain
Katarzyna Pawlik, Joanna Mika
Molecules (2023) Vol. 28, Iss. 15, pp. 5766-5766
Open Access | Times Cited: 15
Interleukin-18 in chronic pain: Focus on pathogenic mechanisms and potential therapeutic targets
Jie Ju, Zheng Li, Xiaoqian Jia, et al.
Pharmacological Research (2024) Vol. 201, pp. 107089-107089
Open Access | Times Cited: 5
A transcriptomic analysis of neuropathic pain in the anterior cingulate cortex after nerve injury
Yu Zhang, Shiwei Jiang, Fei Liao, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 2058-2075
Open Access | Times Cited: 19
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
A Ciechanowska, Ewelina Rojewska, Anna Piotrowska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis
Mushtaq Ahmad Ansari, Ahmed Nadeem, Sabry M. Attia, et al.
Immunobiology (2022) Vol. 227, Iss. 5, pp. 152245-152245
Closed Access | Times Cited: 16
Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model
A Ciechanowska, Katarzyna Pawlik, Katarzyna Ciapała, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 579-579
Open Access | Times Cited: 10
Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics
Katarzyna Ciapała, Joanna Mika
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1624-1624
Open Access | Times Cited: 9
Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
Klaudia Kwiatkowski, Katarzyna Pawlik, Katarzyna Ciapała, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 27
Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain
Katarzyna Pawlik, A Ciechanowska, Katarzyna Ciapała, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model—In Vivo and In Vitro Study
Anna Piotrowska, Katarzyna Ciapała, Katarzyna Pawlik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11074-11074
Open Access | Times Cited: 16
Pharmacological Evidence of the Important Roles of CCR1 and CCR3 and Their Endogenous Ligands CCL2/7/8 in Hypersensitivity Based on a Murine Model of Neuropathic Pain
Katarzyna Pawlik, Katarzyna Ciapała, A Ciechanowska, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 98-98
Open Access | Times Cited: 12
CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain
Joanna Bogacka, Katarzyna Popiołek-Barczyk, Katarzyna Pawlik, et al.
European Journal of Pharmacology (2020) Vol. 880, pp. 173166-173166
Closed Access | Times Cited: 16
Blockade of CCR4 Diminishes Hypersensitivity and Enhances Opioid Analgesia – Evidence from a Mouse Model of Diabetic Neuropathy
Joanna Bogacka, Katarzyna Ciapała, Katarzyna Pawlik, et al.
Neuroscience (2020) Vol. 441, pp. 77-92
Closed Access | Times Cited: 16
Knowing the Enemy Is Halfway towards Victory: A Scoping Review on Opioid-Induced Hyperalgesia
Tiago J. Sampaio-Cunha, Isabel Martins
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6161-6161
Open Access | Times Cited: 10
Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain
Renata Zajączkowska, Klaudia Kwiatkowski, Katarzyna Pawlik, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1310-1322
Open Access | Times Cited: 15
Genetic and functional evidence for gp130/IL6ST-induced transient receptor potential ankyrin 1 upregulation in uninjured but not injured neurons in a mouse model of neuropathic pain
Theodora Kalpachidou, Philipp Malsch, Yanmei Qi, et al.
Pain (2021) Vol. 163, Iss. 3, pp. 579-589
Open Access | Times Cited: 13
Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain
Martina Vincenzi, Michele Stanislaw Milella, Ginevra D’Ottavio, et al.
Life (2022) Vol. 12, Iss. 3, pp. 398-398
Open Access | Times Cited: 8
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain
Yoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, et al.
Oncology Letters (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 4
CCR1 enhances SUMOylation of DGCR8 by up-regulating ERK phosphorylation to promote spinal nerve ligation-induced neuropathic pain
Cunxian Shi, Jin Jin, Hongyu Xu, et al.
Gene Therapy (2021) Vol. 29, Iss. 6, pp. 379-389
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top